78
Participants
Start Date
November 30, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
AFQ056
Placebo
Novartis Investigative Site, Budapest
Novartis Investigative Site, Kaposvár
Novartis Investigative Site, Berlin
Novartis Investigative Site, Beelitz-Heilstätten
Novartis Investigative Site, Donostia / San Sebastian
Novartis Investigative Site, Westerstede/Oldenburg
Novartis Investigative Site, Madrid
Novartis Investigative Site, Pessac
Novartis Investigative Site, Kassel
Novartis Investigative Site, Bolzano
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Bochum
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lille
Novartis Investigative Site, Clermont-Ferrand
Novartis Investigative Site, Englewood
Novartis Investigative Site, München
Novartis Investigative Site, München
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Sunnyvale
Novartis Investigative Site, London
Novartis Investigative Site, Gatineau
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Stadtroda
Novartis Investigative Site, Szeged
Novartis Investigative Site, Roma
Novartis Investigative Site, Sant Cugat del Vallès
Novartis Investigative Site, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY